Blue Trust’s Telix Pharmaceuticals TLX Stock Holding History
Bought
Maintained
Sold
Other funds holding TLX
Blue Trust's TLX Position: Q3 2026 in Review
Blue Trust sold out of Telix Pharmaceuticals (TLX) in Q3 2026, closing a stake of 742 shares — an estimated $8.56K sold.
Blue Trust first reported a position in TLX in Q3 2025 and held it in 4 quarters. The position peaked at $23.1K in Q4 2025. 50 funds tracked by Wall St. Rank hold TLX as of Q3 2026.
- Blue Trust reported no remaining Telix Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Blue Trust sold 742 Telix Pharmaceuticals shares in Q3 2026, an estimated $8.56K.
- Blue Trust first reported a position in Telix Pharmaceuticals in Q3 2025 and held it in 4 quarters.
- Blue Trust's Telix Pharmaceuticals position peaked at $23.1K in Q4 2025.
- 50 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.